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Abstract Charcot–Marie–Tooth type 2B (CMT2B) is a
peripheral ulcero-mutilating neuropathy caused by four
missense mutations in the rab7a gene. CMT2B is clinically
characterized by prominent sensory loss, distal muscle
weakness leading to muscle atrophy, high frequency of foot
ulcers and infections that often results in toe amputations.
RAB7A is a ubiquitous small GTPase, which controls
transport to late endocytic compartments. Although the
biochemical and functional properties of disease-causing
RAB7A mutant proteins have been investigated, it is not
yet clear how the disease originates. To understand how
mutations in a ubiquitous protein specifically affect
peripheral neurons, we performed a two-hybrid screen
using a dorsal root ganglia cDNA library with the purpose
of identifying RAB7A interactors specific for these cells.
We identified peripherin, an intermediate filament protein
expressed primarily in peripheral neurons, as a putative
RAB7A interacting protein. The interaction was confirmed
by co-immunoprecipitation and pull-down experiments,
and established that the interaction is direct using recom-
binant proteins. Silencing or overexpression of wild type
RAB7A changed the soluble/insoluble rate of peripherin
indicating that RAB7A is important for peripherin orga-
nization and function. In addition, disease-causing RAB7A
mutant proteins bind more strongly to peripherin and their
expression causes a significant increase in the amount of
soluble peripherin. Since peripherin plays a role not only in
neurite outgrowth during development but also in axonal
regeneration after injury, these data suggest that the altered
interaction between disease-causing RAB7A mutants and
peripherin could play an important role in CMT2B
neuropathy.
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Introduction
Charcot–Marie–Tooth (CMT) disease is a group of genet-
ically and clinically heterogeneous neuronal disorders [76,
79]. This neuropathy, also called hereditary motor and
sensory neuropathy (HMSN), has a prevalence of 1:2,500
and its onset is usually within the first or second decade of
life. CMT disease has a major impact on motor and sensory
neurons and is characterized by progressive weakness of
the distal muscles, first affecting lower legs and feet and
then leading to muscle atrophy [6, 70, 81]. CMT type 2B
(CMT2B) is an axonal autosomal dominant form of the
neuropathy characterized by prominent distal sensory loss,
muscle weakness and atrophy, and frequent ulcers leading
L. Cogli  C. Progida  C. Donno  C. Bucci (&)
Department of Biological and Environmental Sciences
and Technologies (DiSTeBA), University of Salento,
Via Provinciale Monteroni 165, 73100 Lecce, Italy
e-mail: cecilia.bucci@unisalento.it
C. L. Thomas  G. Schiavo
Molecular NeuroPathobiology, Cancer Research UK London
Research Institute, 44 Lincoln’s Inn Fields,
London WC2A 3LY, UK
B. Spencer-Dene
Experimental Pathology Laboratories, Cancer Research UK
London Research Institute, 44 Lincoln’s Inn Fields,
London WC2A 3LY, UK
Present Address:
C. Progida
Department of Molecular Biosciences, Centre for Immune
Regulation, University of Oslo, 0316 Oslo, Norway
123
Acta Neuropathol (2013) 125:257–272
DOI 10.1007/s00401-012-1063-8
to toe amputations, resulting in the alternative name of
ulcero-mutilating neuropathy [1, 80]. Four missense
mutations in the rab7a gene on chromosome 3q21 cause
CMT2B [30, 50, 66, 88]. RAB proteins are small GTPases
involved in the regulation of vesicular intracellular traf-
ficking and signal transduction [17, 83]. Indeed, they
participate in several steps of membrane traffic being
involved in budding, moving, tethering and fusion of ves-
icles to the target compartment [83].
Two different forms of RAB7 have been identified. In
addition to RAB7A, a close homologue that displays high
sequence similarity to RAB7A has been identified and called
RAB7B [96]. RAB7A and RAB7B have different functions:
RAB7A is localized to late endosomes and controls transport
to late endosomes and lysosomes as well as maturation of
phagosomes and autophagosomes [19, 21, 28, 47, 54], while
RAB7B controls transport from endosomes to the Golgi
apparatus [73, 74]. The CMT2B-causing RAB7A mutant
proteins have altered GDP/GTP cycle, resulting in an
increased nucleotide dissociation rate constant (Koff) for both
GDP and GTP. As such, these mutants release bound nucle-
otides faster than the wild type (wt) protein and, consequently,
they show also impaired GTPase activity per binding event
[37, 63, 82]. In addition, these mutant proteins show a much
higher Koff for GDP than for GTP and thus they are predom-
inantly in the GTP-bound form in the cell and they bind more
strongly to several RAB7A effectors [37, 63, 82].
Importantly, RAB7A controls axonal retrograde traf-
ficking and signaling of the nerve growth factor (NGF)
receptor TrkA [39, 78]. As a result, expression of the
RAB7A T22 N dominant negative mutant causes a strong
increase in neurite outgrowth [78]. Accordingly, CMT2B-
causing RAB7A mutant proteins alter TrkA and Erk1/2
endosomal signaling in response to NGF, leading to a
strong inhibition of neurite outgrowth in different cell lines
[9, 34, 95]. Although these biochemical and functional data
obtained with CMT-causing RAB7A mutants start to
unravel the molecular mechanisms underlying CMT2B, it
is not yet clear why expression of these mutant proteins
specifically lead to a peripheral neuropathy [33].
In the present study, we decided to search for RAB7A
interactors in dorsal root ganglia (DRG) cells to explain
how mutations in a ubiquitous protein mainly affect
peripheral neurons. Here, we report for the first time that
RAB7A interacts directly with peripherin, a 57 kDa type
III neuronal intermediate filament protein.
Intermediate filaments are a major component of the
cytoskeleton, important for organelle positioning, transport
and function [49]. Peripherin is primarily expressed in
peripheral neurons and in discrete populations of CNS
neurons that project towards peripheral structures [5, 13,
42, 59, 71, 72]. Peripherin is mutated in amyotrophic lat-
eral sclerosis (ALS) and a neurotoxic splice variant has
been identified in a mouse model of ALS [45, 60, 77, 94].
Also, an aggregate-inducing peripherin isoform is upregu-
lated in ALS [94]. Importantly, peripherin is thought to be
important in axonal regeneration [25, 26, 61, 67, 92].
Indeed, it has been suggested that the regeneration program
is at least in part based on changes to intermediate filament
composition and dynamics [87, 92]. In particular, peri-
pherin is differentially regulated in regenerating and non-
regenerating sensory neurons, and it plays a role during the
elongation of motor axons [25, 75, 87, 92]. The abnor-
malities in the binding of peripherin to disease-causing
RAB7A mutants described in this manuscript suggest that
the interaction of this small GTPase to specific components
of the neuronal cytoskeleton could be an important mech-
anism in the pathogenesis of CMT2B.
Materials and methods
Cells and reagents
All chemicals and cell culture reagents were purchased
from Sigma-Aldrich (St. Louis, MO, USA). Restriction and
modification enzymes were from New England Biolabs
(Ipswich, MA, USA). HeLa (human cervix carcinoma),
PC12 (rat pheochromocytoma) and Neuro2A (mouse neu-
roblastoma) cell lines were grown in DMEM supplemented
with 10 % heat-inactivated fetal calf serum, 2 mM gluta-
mine, 100 U/ml penicillin and 10 mg/ml streptomycin, in a
5 % CO2 incubator at 37 C. For all experiments, only
cells at passage number \20 were used.
Neuronal cultures
DRG neurons were isolated from E13.5 mouse embryos
using standard procedures [46]. Briefly, ganglia were iso-
lated in Hank’s buffered salt solution (HBSS) and digested
in collagenase IV (C5138; Sigma Aldrich, Dorset, UK)/
dispase II (165 859; Roche Diagnostics Ltd. West Sussex,
UK) for 40 min at 37 C. The cell pellet was triturated with
a fire-polished Pasteur pipette in 2 ml HBSS. A 5-ml
solution of Percoll (17089102; GE Healthcare Life Sci-
ences, Buckinghamshire, UK) in L-15 medium (1 ml
Percoll mixed with 4 ml L-15) was then carefully added to
the bottom of a Falcon tube. Dissociated DRG neurons
were centrifuged through this Percoll cushion for 8 min at
380g. Cells were washed with 2 ml L-15 medium, re-
centrifuged as before and then resuspended in a minimum
volume of bare-bones medium [46] supplemented with
200 ng/ml NGF. DRG neurons were plated on poly-orni-
thine and laminin-coated coverslips and kept in complete
medium in a 7.5 % CO2 humidified incubator at 37 C for
5 days.
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Two-hybrid assay
5 lg of human DRG total RNA (CH636150; Takara Bio
Europe/Clontech, Saint-Germain-en-Laye, France) was
used to construct a two-hybrid cDNA library using a kit
(CH630445; Clontech) following the manufacturer’s
instructions. The library encodes proteins as C-terminal
fusions with the GAL4 transcriptional activation domain in
the pGADT7Rec vector.
A GAL4-binding domain/RAB7A DC fusion construct
in the pGBKT7 vector encoding canine RAB7A was used
to screen our custom-made DRG cDNA library using
AH109 yeast cells [7, 8, 31]. Transformants were plated
onto synthetic medium lacking His, Leu, and Trp and
clones were picked up after 5–6 days at 30 C. Specificity
tests using the PGBKT7 vector, pGBKT7-RAB7A wt,
pGBKT7-RAB7B wt or pGBKT7 peripherin, and PGAD-
T7Rec-peripherin or PGADT7Rec-RAB7A wt constructs
were performed. Clones were then assayed for growth on
selective medium and for b-galactosidase activity using
o-nitrophenyl-b-D-galactoside as a substrate as previously
described [7, 8, 31].
Plasmid construction
The RAB7A plasmids used in this study have been
described previously [21, 35, 37, 82, 89]. MYC-tagged
peripherin was obtained from Origene (RC207561). Peri-
pherin ORF was transferred using AsiSI and MluI
restriction enzymes to pCMV6-AN-HA (Origene,
PS100013) to obtain a vector for the expression of HA-
tagged peripherin. Peripherin ORF was amplified by PCR
using the following oligonucleotides: 50-ACGCGGATCC
ATGAGCCACCACCCGTCGG-30 and 50-CCGGAATTCT
CAGTAACTGTGGGCAGAAG-30 and cloned in the
pGEX4T3 vector using BamHI and EcoRI restriction sites
to obtain a plasmid for the bacterial expression of GST-
tagged peripherin. Peripherin 45 mutant was generated
from peripherin cDNA using the following oligonucleo-
tides: 50-ATAGCGATCGCCATGGCCGAGGCCCTCAA
C-30 and 50-CCGCGTACGCGTGTAACTGTGGGC-30 and
then cloned with AsiSi and MluI restriction enzymes into the
myc-tagged vector. All constructs were sequence verified.
Transfection and RNA interference
Transfection in Neuro2A and HeLa cells was performed
using Metafectene Pro or Metafectene Easy from Biontex
(Karlsruhe, D), following the manufacturer’s instructions.
After 20 h, transfected cells were processed for immuno-
fluorescence or biochemical assays. For RNA interference,
siRNAs were purchased from MWG-Biotech (Ebersberg,
D). We used the following oligonucleotides: siRNA mouse
rab7a, sense sequence 50-GGAUGACCUCUAGGAAGA
ATT-30 and antisense sequence 50-UUCUUCCUAGAGGU
CAUCCTT-30. As a negative control, we used a scrambled
sequence: sense scrambled control 50-ACUUCGAGCGUG
CAUGGCUTT-30 and antisense scrambled control 50-AGC
CAUGCACGCUCGAAGUTT-30. Briefly, Neuro2A cells
were plated 1 day before transfection in tissue culture
dishes (6 cm diameter). Cells were transfected with siR-
NAs using Metafectene Si from Biontex (Karlsruhe, D) for
72 h and then processed for further assays.
Co-immunoprecipitation and pull-down
For co-immunoprecipitation 25 ll of anti-HA or anti-MYC
resin (Ezview Red Anti-HA or anti-Myc affinity gel from
Sigma) was used according to the manufacturer’s instruc-
tions. Briefly, HeLa or Neuro2A cells were lysed with RIPA
buffer (R078; Sigma-Alrich), centrifuged at 8,000 g to
pellet nuclei, cellular debris and unbroken cells, and
supernatants were incubated with the anti-HA or anti-MYC
resin for 1 h at 4 C on a rotating wheel. Immunoprecipitated
samples were then loaded on SDS-PAGE and analyzed by
western blotting. Co-immunoprecipitation of endogenous
proteins was performed in Neuro2A cells using a crosslink
immunoprecipitation kit (Pierce) following the manufac-
turer’s instructions. Briefly, mouse anti-RAB7 antibody
(Sigma) or mouse IgG was crosslinked to a resin using dis-
uccimidyl suberate (DSS) and incubated with pre-cleared
Neuro2A lysate. After washing and elution immunoprecipi-
tates were subjected to western blotting analysis using rabbit
anti-RAB7A and anti-peripherin antibodies.
For pull-down His-tagged RAB7A wt and mutant pro-
teins were expressed and purified from E. coli as previously
described [29]. After purification, 20 lg of each purified
protein was bound to NiNTA resin at 4 C for 45 min. The
resin was then washed three times for 5 min with a
washing solution (NaH2PO4 50 mM, NaCl 300 mM,
imidazole 20 mM, pH 8.0) and incubated with Neuro2A
cell extracts at 4 C for 1 h. After washing, samples were
loaded on SDS-PAGE and analyzed by western blotting.
For direct interaction GST, GST- and His-tagged pro-
teins were expressed in bacteria and affinity purified as
described [23, 29]. His-tagged RAB7A was incubated
alone or in combination with GST or GST-tagged peri-
pherin in PBS with 2 mM MgCl2 and GTP 0.8 mM for 1 h
on a rotating wheel. Subsequently, pull-down was per-
formed using a glutathione resin [40]. Samples were then
subjected to SDS-PAGE and western blotting.
Antibodies
Mouse monoclonal 9E10 anti-Myc (ab32), rabbit poly-
clonal anti-HA (ab9110) and rabbit polyclonal anti-
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peripherin 61 (ab4646) antibodies were from Abcam
(Cambridge, UK), rabbit polyclonal anti-RAB7A (R4779,
used at 1:500) and mouse monoclonal anti-a-tubulin
(T5168) were from Sigma, while anti-peripherin antibodies
(sc-7604) were from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Primary antibodies were used at a 1:1,000
unless otherwise indicated. Secondary antibodies conju-
gated with fluorochromes or HRP were from Invitrogen
(Milan, Italy) or Santa Cruz Biotechnology and used at
1:5,000 dilution.
Western blotting
Total cell extracts were prepared by lysing the cells in
62.5 mM Tris–HCl, pH 6.8, containing 2 % (w/v) SDS and
protease inhibitor cocktail. Differential extraction of solu-
bile and filamentous peripherin (solubile and insolubile
fractions) was performed as previously described [64].
Briefly, cells were harvested in low salt Triton-X100 buffer
and incubated on ice for 30 min. Soluble and insoluble
fractions were then separated by centrifugation. Fractions
were loaded onto SDS-PAGE and separated proteins were
transferred onto polyvinyl difluoride (PVDF) membranes
from Millipore (Milan, Italy). The filter was blocked in
5 % milk in PBS for 30 min at room temperature, incu-
bated with the appropriate antibody and then with a
secondary antibody conjugated with HRP (diluted 1:5,000).
Bands were visualized using enhanced chemiluminescence
(GE, Milan, Italy) or western blotting Luminol Reagent
(SantaCruz Biotechnology).
Animal experiments
All animal experiments were carried out under license from
the UK Home Office in accordance with the Animals
(Scientific Procedures) Act 1986 and following approval
from the Cancer Research UK Ethical Review Committee.
Wt C57BL/6 mice were housed in a controlled temperature
and humidity environment and maintained on a 12 h light/
dark cycle with access to food and water provided ad libi-
tum. Mice were terminally anaesthetized with sodium
pentobarbitone and transcardially perfused with 4 % (w/v)
paraformaldehyde in 0.1 M PBS.
Immunofluorescence microscopy
Neuro2A cells grown on 12-mm round glass coverslips
were permeabilized, fixed and incubated with primary and
secondary antibodies as described previously [20, 22].
Images of Neuro2A cells represent maximum-intensity
projections of Z stacks.
DRGs were fixed with 4 % paraformaldehyde (PFA) in
PBS, permeabilized for 15 min with 0.1 % Triton X-100 in
PBS, washed and blocked with 2 % bovine serum albumin
(BSA) in PBS (blocking solution) for 1 h. Immunostaining
with goat polyclonal anti-peripherin (sc7604, Santa Cruz;
1:100), rabbit monoclonal anti-RAB7A (9367S, Cell Sig-
naling; 1:20) or mouse monoclonal anti-RAB7A (R8779,
Sigma; 1:200) was carried out for 1 h in blocking solution
followed by AlexaFluor555-conjugated anti-goat and Al-
exaFluor488-conjugated anti-rabbit secondary antibodies
(30 min). All washes were in PBS except for final wash
with water before mounting coverslips.
Sciatic nerves were removed, post-fixed overnight and
then arranged in a longitudinal orientation in 2 % agarose
before paraffin processing, embedding and sectioning at
4 lM onto charged slides. Sections were blocked with
10 % normal donkey serum/1 % BSA and stained over-
night at 4 C with rabbit monoclonal anti-RAB7A and goat
polyclonal anti-peripherin. Following extensive washing,
sections were stained with donkey secondary antibodies for
1 h at room temperature, washed and then mounted in
Hardset Mount containing DAPI (Vector). The antibodies
all required 15 min microwaving in 0.1 M citrate buffer pH
6.0 for antigen retrieval.
Samples were imaged by confocal microscopy with a
Zeiss LSM 510 equipped with a 639, 1.4 NA Plan Apo-
chromat oil-immersion objective. Images were processed
using Zeiss LSM 510 software.
Quantification and statistical analysis
Protein levels were quantified by densitometry using the
ImageJ software. The levels of peripherin were normalized
against a-tubulin or against RAB7A, and analyzed statis-
tically using the Student’s t test for unpaired data. The
analysis was based on the comparison of cells expressing a
HA-tagged RAB7A mutant protein and cells expressing
HA-tagged RAB7A or control cells as indicated.
Results
Identification of peripherin as a RAB7A interacting
protein
To identify novel RAB7A-interacting proteins specific for
peripheral neurons, we decided to construct a human DRG
cDNA library suitable for two-hybrid screens and use a
Gal4-binding domain/RAB7A fusion construct as a bait.
The final three amino acids of RAB7A (Cys-Ser-Cys) were
deleted to prevent C-terminal prenylation as such modifi-
cation might cause high background in the assay. From
1 9 106 primary transformants and 27 putative positive
clones, 11 were encoding putative true positives that did
not activate transcription in the presence of a non-specific
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test bait. Five of the positive clones were encoding Rab
Interacting Lysosomal Protein (RILP) and one Prenylated
Rab Acceptor 1 (PRA1), two previously identified RAB7A
interacting proteins [18, 23]. The remaining five clones
contained part of the coding region and the 30 untranslated
region of peripherin cDNA, with the longest peripherin
clone encoding from residue 280 to the end of the protein.
The specificity of the interaction of RAB7A and peripherin
was confirmed by the growth of yeast cells expressing
RAB7A wt and peripherin on synthetic medium lacking
leucine, tryptophan and histidine (Fig. 1a). In contrast,
yeast cells expressing peripherin alone or together with
RAB7B were unable to grow without histidine (Fig. 1a).
The specificity of this interaction was also confirmed using
a quantitative b-galactosidase assay (Fig. 1b). Importantly,
we tested in this system the ability of peripherin to interact
with the different RAB7A mutant proteins: the dominant
negative RAB7A T22 N, the constitutively active RAB7A
Q67L and the CMT2B-causing mutants RAB7A L129F,
RAB7A K157 N, RAB7A N161T and RAB7A V162 M.
As shown in Fig. 1, all RAB7A mutant proteins efficiently
interact with peripherin.
CMT2B-causing RAB7A mutant proteins show altered
interaction with peripherin
To confirm the results obtained with the two-hybrid
screening, we investigated whether RAB7A and peripherin
co-immunoprecipitate in Neuro2A cells. This cell line and
PC12 cells are ideal cellular models to study the RAB7A-
peripherin interaction since they both express endogenous
peripherin [2, 65]. Neuro2A cells were transfected with
HA-tagged or MYC-tagged RAB7A wt and immunopre-
cipitated using anti-HA or anti-MYC beads. Both HA-
tagged (Fig. 2a) and MYC-tagged (Fig. 2b) RAB7A
immunoprecipitates contained peripherin, thus confirming
that the two proteins exist in a complex in Neuro2A cells.
Interestingly, the RAB7A Q67L constitutively active mutant
and the disease-causing mutant proteins RAB7A L129F,
RAB7A K157 N, RAB7A N161T and RAB7A V162 M were
all able to co-immunoprecipitate peripherin more efficiently
then RAB7A wt, thus demonstrating that they interact more
strongly with peripherin (Fig. 2a). Indeed, quantification of
three independent experiments indicates that disease-causing
RAB7A mutant proteins are able to co-immunoprecipitate
peripherin about 60 % more efficiently than RAB7A wt
(Fig. 2c). Similar results were obtained in PC12 cells (data not
shown). Strikingly, this binding was also shown using endoge-
nous proteins (Fig. 2d), suggesting that the interaction between
RAB7A and peripherin is of physiological significance.
We then incubated recombinant His-RAB7A with
Neuro2A extracts. His-RAB7A wt was able to pull-down
peripherin, thus providing an independent confirmation of the
interaction between these two proteins (Fig. 3a). Importantly,
pull-down was more efficient when the constitutively active
RAB7A Q67L mutant or the CMT2B RAB7A mutants were
used (Fig. 3a). Quantification revealed that these mutant
proteins were able to pull-down twofold levels of peripherin
compared to RAB7A wt (Fig. 3b).
Finally, we used pull-downs of recombinant purified
proteins to test whether the interaction between RAB7A
and peripherin is direct. To this end, bacterially expressed
GST or GST-tagged peripherin was incubated with purified
His-RAB7A and then subjected to GST pull-down using a
glutathione resin. The resin was then extensively washed
and bound proteins were analyzed by western blot.
Strikingly, anti-RAB7A antibodies recognized a band
Fig. 1 Specific interaction between RAB7A and peripherin in the
two-hybrid system. a Yeast AH109 cells transformed with PGBKT7
vector, PGBKT7-rab7b wt or PGBKT7-rab7a wt or mutant con-
structs, and with pGADT7Rec vector, pGADT7Rec-peripherin or
pGADT7Rec-RAB7A wt, as indicated, were plated on -WL and
-HWL synthetic medium and incubated at 30 C for 2 days. b The
indicated double transformants of PGBKT7-rab7b wt, PGBKT7-
rab7a wt or mutant constructs, and pGADT7Rec-peripherin were
assayed for b-galactosidase liquid assay using ONPG as substrate in
order to quantify the interaction. The values represent the mean of
three independent experiments ± standard deviation
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corresponding to His-RAB7A only in the GST-peripherin
sample (Fig. 3c). Altogether these data indicate that
RAB7A interacts directly with peripherin and that
CMT2B-causing RAB7A mutant proteins bind peripherin
more efficiently than RAB7A wt.
In addition to the main form of peripherin with an apparent
molecular weight of 58 kDa (also called Per-58), other iso-
forms of peripherin derived from alternative splicing and/or
intron retention have been identified in mammalian cells,
such as Per-61, Per-56, Per-45 and Per-28 [64, 65]; novel
forms may also be present [64, 65, 77, 94]. Interestingly, the
binding of RAB7A is not restricted to Per-58 since RAB7A
was shown to interact with endogenous Per-61 in Neuro2A
cells, using a specific antibody for this isoform, and with
overexpressed Per-45 in HeLa cells (Fig. 3d, e).
Intracellular localization of RAB7A and peripherin
We then investigated the intracellular localization of
RAB7A and peripherin in Neuro2A cell using confocal
immunofluorescence analysis (Fig. 4). As expected, anti-
RAB7A antibodies labeled vesicles and organelles, often
concentrated in the perinuclear region, while the anti-per-
ipherin stained a filamentous network that was also
localized in cell protrusions (Fig. 4a). Interestingly,
RAB7A-bearing vesicles were sometimes seen colocaliz-
ing with peripherin filaments (Fig. 4a, insets, arrowheads).
To confirm these findings, we performed confocal immu-
nofluorescence analysis using anti-peripherin antibodies on
Neuro2A cells overexpressing GFP, GFP-RAB7A wt and
GFP-RAB7B wt (Fig. 4b, c). As previously reported, GFP-
tagged RAB7A wt was present on cytosolic vesicles and its
overexpression caused enlargement and clustering of these
vesicles in the perinuclear region (Fig. 4b) [21]. This analysis
revealed a very limited but consistent co-localization of
RAB7A with peripherin. In particular, some RAB7A-positive
vesicles were seen to lie over peripherin filaments (Fig. 4b,
insets, arrowheads). No similar close association of vesicles
with peripherin filaments was observed in cells overexpress-
ing GFP or GFP-RAB7B (Fig. 4c).
Fig. 2 RAB7A co-immunoprecipitates with peripherin. a HA-tagged
RAB7A wt and mutant proteins were expressed in Neuro2A cells, as
indicated, immunoprecipitated with an anti-HA antibody and sub-
jected to western blot analysis using anti-peripherin and anti-HA
antibodies. b Immunoprecipitates obtained from Neuro2A cells
expressing MYC-tagged RAB7A wt using an anti-MYC antibody
were subjected to western blot analysis with anti-peripherin and anti-
MYC antibodies. c Quantification of immunoprecipitated peripherin.
Values are the mean of three independent experiments ± standard
deviation. The intensities were quantified by densitometry,
normalized against the amount of the RAB7A wt or mutant protein
present, and plotted as a percentage of the intensities obtained using
RAB7A wt. Data were analyzed statistically using unpaired Student’s
t test. The values of cells expressing RAB7A mutant proteins were
found to be significantly different from the values of cells expressing
RAB7A wt (*p \ 0.05, **p \ 0.01, ***p \ 0.001). d Total extracts
of Neuro2A cells and immunoprecipitates obtained with no antibodies
(no ab), with mouse anti-RAB7A and with mouse IgG were subjected
to WB analysis using rabbit anti-RAB7A and rabbit anti-peripherin
antibodies
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A similar pattern was also detected when CMT2B-
causative RAB7A mutant proteins were expressed (Fig. 5).
Indeed, vesicle-bearing RAB7A mutants were found in
close proximity to peripherin filaments (Fig. 5, insets,
arrowheads).
We also tested the colocalization of endogenous peri-
pherin and RAB7 in embryonic DRGs neurons, a well-
established model of sensory neurons. As shown in Fig. 6,
peripherin displays an extensive staining of the neuronal
network, which is expected from its established role in the
neuronal cytoskeleton [32]. In contrast, RAB7A antibodies
label punctate structures widely distributed in the neuronal
network and in the cell body (Fig. 6a), which are often
juxtaposed to peripherin filaments (Fig. 6b, c). This partial
co-distribution is also observed in sections of the sciatic
nerve (Fig. 6d), confirming that RAB7A-positive
Fig. 3 RAB7A interacts with peripherin and with peripherin’s
isoforms 45 and 61. a Bacterially expressed and affinity purified
His-tagged RAB7A wt and mutant proteins were incubated with total
extract of Neuro2A cells, purified with NiNTA resin and subjected to
western blot analysis using anti-RAB7A and anti-peripherin antibod-
ies, as indicated. b Quantification of pulled down peripherin. The
values represent the mean of four independent experiments ± stan-
dard deviation. The intensities were quantified by densitometry,
normalized against the amount of the RAB7A wt or mutant protein
present and plotted as a percentage of the intensities obtained using
RAB7A wt. Values obtained using disease-causing RAB7A mutant
proteins were found to be significantly different form the values
obtained with RAB7A wt (*p \ 0.05, **p \ 0.01, ***p \ 0.001).
c Bacterially expressed GST or GST-peripherin immobilized on a
glutathione resin, or a glutathione resin alone were incubated with
purified His-RAB7A. Samples were then subjected to western blot
analysis using anti-RAB7A and anti-GST antibodies. d Immunopre-
cipitates obtained from total extracts of Neuro2A cells overexpressing
HA-RAB7A wt using anti-HA antibodies were subjected to western
blot analysis using anti-HA and anti-peripherin 61 antibodies. e Total
extracts of control HeLa cells (NT) or of cells expressing HA-RAB7A
wt, MYC-peripherin 45 and/or MYC-peripherin 58, as indicated, were
subjected to immunoprecipitation using anti-HA antibody and then to
western blot analysis using anti-peripherin and anti-HA antibodies
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organelles and peripherin are likely to be in close contact
both in vitro and in vivo.
RAB7A regulates peripherin assembly
To start to understand the functional meaning of this
interaction, we first decided to investigate whether RAB7A
could alter the total amount of peripherin. RAB7A knock-
down using RNA interference reduced rab7a mRNA levels
to less than 20 % (data not shown) and endogenous
RAB7A protein was no longer detectable by western blot
(Figs. 7, 8). However, the total amount of peripherin in
RAB7A-silenced Neuro2A cells was not changed signifi-
cantly (Fig. 7a). Consistently, overexpression of HA-
tagged RAB7A wt or mutants did not alter the total amount
of peripherin in these cells (Fig. 7b).
Intermediate filaments are insoluble protein polymers
that are assembled from soluble precursors [41, 49].
Intermediate filament proteins self-assemble to form
coiled-coil dimers that associate laterally to form tetra-
meric complexes. Monomers, dimers and tetramers are
entirely soluble. Tetramers associate laterally to form short
filaments (also known as unit-length filaments) that longi-
tudinally anneal to assemble long filaments that are highly
insoluble under physiological conditions [41, 49]. Peri-
pherin is assembled from soluble precursors in a similar
way [44], thus soluble peripherin precursors could be
separated from the insoluble peripherin filaments, and the
peripherin soluble/insoluble ratio determined.
To check whether RAB7A influences peripherin orga-
nization, we decided to monitor the amount of peripherin
present in the soluble and insoluble fractions in RAB7A-
depleted Neuro2A cells. Interestingly, rab7a silencing
caused a redistribution of peripherin with a decrease of the
amount of peripherin in the soluble fraction and an increase
in the insoluble fraction (Fig. 8a, b) as quantified in
Fig. 8c. Consistently, expression of HA-tagged RAB7A wt




Rab7 mutant proteins and
peripherin. Neuro2A cells
overexpressing GFP-RAB7A
mutant proteins (green), as
indicated, were subjected to
immunofluorescence analysis
using an anti-peripherin
antibody followed by a Cy3
secondary antibody (red).
Images represent maximum-
intensity projections of Z stacks.
For each image, magnification
of the boxed areas is shown in
the respective lower insets.
Arrowheads point to RAB7A
mutants-positive vesicles
colocalizing to peripherin
filaments. Scale bars 10 lm
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peripherin and a decrease in the amount of insoluble per-
ipherin (Fig. 8d, e). Importantly, a stronger increase of
soluble peripherin was observed upon expression of the
HA-tagged RAB7A Q67L constitutively active mutant and
the increase was even stronger upon expression of
CMT2B-inducing RAB7A mutants (Fig. 8d). Quantifica-
tion of four independent experiments indicated that upon
expression of CMT2B-causing RAB7A mutants, soluble
peripherin increased about threefold (Fig. 8e). In line with
these results the presence of peripherin in the insoluble
fraction diminished (Fig. 8e). Similar data were obtained in
PC12 cells (data not shown).
Discussion
Our results demonstrate a novel direct interaction between
the small GTPase RAB7A and peripherin, a component of
the intermediate filament cytoskeleton. Rab proteins act as
master regulators of intracellular membrane traffic. Vesicle
formation, their movement on cytoskeletal tracks, tether-
ing, recognition and fusion to the target compartment are
processes regulated by one or more of these small GTPases
[83]. Intermediate filaments have also been directly con-
nected with the regulation of membrane trafficking, as they
are involved in organelle positioning and function [27, 44,
68, 84]. Indeed, intermediate filaments interact with several
types of organelles, such as the nucleus, mitochondria, the
Golgi apparatus, endosomes and lysosomes. In particular,
neurofilaments are intimately connected with mitochondria
and disruption of these connections alters mitochondrial
morphology, distribution and functionality [24, 90]. Sev-
eral intermediate filament proteins, such as vimentin,
peripherin and a-internexin, are associated with the endo-
somal adaptor complex AP3 that mediates trafficking of
cargo proteins to lysosome-related organelles [85]. Chan-
ges in the intermediate filament network alter not only the
intracellular distribution of AP3 but also the positioning
and functionality of late endosomes and lysosomes dem-
onstrating a strong link between intermediate filaments and
the endocytic pathway [85]. Our novel findings reporting
the interaction between RAB7A and peripherin confirm the
close functional relationship between intermediate fila-
ments and regulators of endocytic trafficking. Moreover,
our observation that RAB7A regulates peripherin soluble/
insoluble ratio (Fig. 8) corroborates this hypothesis sug-
gesting, for the first time, that RAB proteins could also
direct vesicular trafficking by controlling intermediate fil-
ament dynamics.
Peripherin is predominantly expressed in the peripheral
nervous systems and also in CNS neurons projecting
towards peripheral structures [5, 13, 42, 59, 71, 72]. In
particular, peripherin expression has been demonstrated in
cranial nerves and spinal cord neurons, including motor
neurons. Indeed, peripherin is expressed in cholinergic
laterodorsal tegmentum (LDT) and pedunculopontine teg-
mentum (PPT) nuclei as well as in tuberomammellary
neurons of the posterior hypothalamus [5, 13, 42, 59, 71,
72]. The presence of RAB7A effector protein expressed
only in certain kinds of neurons and, in particular, in
Fig. 7 Altered expression of RAB7A does not alter peripherin levels.
a Neuro2A cells were treated with control scrambled RNA (scr) or
with rab7a siRNA as indicated. Total extracts were subjected to
western blot analysis using anti-RAB7A and anti-peripherin antibod-
ies. b Quantification of peripherin in rab7a-silenced cells. The values
represent the mean of six independent experiments ± standard error.
The intensities were quantified by densitometry, normalized against
the amount of a-tubulin and plotted as a percentage of the intensities
obtained in cells transfected with control RNA (scr). c Total extracts
of Neuro2A control cells or cells overexpressing RAB7A wt and
mutant proteins, as indicated, were subjected to western blot analysis
using anti-peripherin and anti-HA antibody
Fig. 6 RAB7A and peripherin are co-expressed in DRGs and in the
sciatic nerve. a Peripherin displays a filamentous distribution in the
axonal network of embryonic DRGs cultured in vitro, which overlaps
with RAB7A staining. b, c At close inspection, Rab7-positive
organelles are often in close apposition to peripherin filaments
(arrowheads point to RAB7-positive vesicles which overlap to
peripherin staining). Similar results were obtained with two different
RAB7A antibodies and are confirmed by the staining of Rab7 and
peripherin in mouse sciatic nerve (d). d Both RAB7A and peripherin
are co-expressed in a subset of nerve fibers, where RAB7A-positive
organelles juxtapose to peripherin filaments. Scale bars 10 lm
b
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neurons of the peripheral nervous system might explain
why mutations in a ubiquitous protein such as RAB7A
cause a specific peripheral neuropathy. As a consequence,
these considerations are likely to prompt searches for
specific neuronal effectors of other ubiquitous proteins,
whose mutations specifically affect the nervous system.
Peripherin is a neuronal differentiation marker induced
by stimulation with NGF that has been suggested to have a
role in neuritogenesis, axonal outgrowth and axonal
regeneration [2, 4, 11, 43, 48, 56, 86]. Importantly, over-
expression of peripherin causes degeneration of motor
axons during aging inducing neuron dysfunction and the
Fig. 8 RAB7A regulates soluble/insoluble ratio of peripherin. a,
b Neuro2A cells were treated with control scrambled RNA (scr) or
with rab7a siRNA as indicated. Soluble and insoluble fractions were
separated as described in ‘‘Materials and methods’’, loaded on SDS-
PAGE and subjected to western blot analysis using anti-peripherin
(a), anti-a-tubulin (a) and anti-RAB7A (b) antibodies. c Quantifica-
tion of peripherin in rab7a-silenced cells. The values represent
the mean of three independent experiments ± standard deviation. The
intensities were quantified by densitometry, normalized against the
amount of a-tubulin and plotted as a percentage of the intensities
obtained in cells transfected with control RNA (scr). d Neuro2A
control cells (NT) or expressing HA-tagged RAB7A wt and mutant
proteins as indicated were lysed. Soluble and insoluble fractions were
collected from each sample, loaded on SDS-PAGE and subjected to
western blot analysis using anti-peripherin, anti-a-tubulin and anti-
HA antibodies. e Quantification of soluble and insoluble peripherin.
The values represent the mean of four independent experi-
ments ± standard deviation. The intensities were quantified by
densitometry, normalized against the amount of a-tubulin and plotted
as a percentage of the intensities obtained in control cells (cells
transfected with an empty vector). Values obtained expressing
disease-causing RAB7A mutant proteins were found to be signifi-
cantly different from the values obtained in control cells (*p \ 0.05,
**p \ 0.01, ***p \ 0.001)
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slowing down of neurofilament protein transport [10, 58,
67]. Peripherin overexpression also induces aberrant
intermediate filament phosphorylation and the formation of
neuronal intermediate filament aggregates, which cause
swelling of ER and mitochondria [58]. Interestingly, peri-
pherin is associated with pathological aggregates in
patients with ALS and rare mutations in peripherin were
identified in some sporadic ALS cases [36, 94]. Moreover,
in a mouse model of ALS, a splice variant of peripherin
seems to contribute to neurodegeneration [77]. Based on
the data suggesting a role of peripherin in axonal outgrowth
and our findings discussed above, we propose that the
binding of peripherin to CMT2B-causing RAB7A mutants
alters peripherin functions thus affecting neurofilament
dynamics and as a consequence neurite outgrowth and
axonal regeneration. This is particularly important since
the possibility that CMT2B is caused by defects of axonal
regeneration has not been yet explored. In addition, the
exact role(s) of peripherin in neuronal differentiation and
homeostasis is still unclear and what must also be con-
sidered is that peripherin-null mice failed to show strong
phenotypes [42, 57].
The fact that RAB7A could regulate peripherin assem-
bly and thus peripherin functions reveals a new mechanism
that may potentially explain the peripheral neuropathy
caused by RAB7A mutations. Indeed, we have demon-
strated that CMT2B-causative RAB7A mutants bind more
strongly to peripherin compared to RAB7A wt (Figs. 2, 3).
Although their expression does not change the total levels
of peripherin (Fig. 7), CMT2B-causative RAB7A mutants
alter the peripherin soluble/insoluble ratio (Fig. 8), sug-
gesting that the process of peripherin filament assembly is
at least in part compromised. Peripherin and neurofilament
triplet proteins co-assemble and are functionally interdepen-
dent [97]. Notably, peripherin mutations disrupt the
neurofilament network while deletion of the neurofilament
light gene leads to a reduction of peripherin in mouse sciatic
nerve [45, 97]. In view of these data it is interesting to note
that other forms of CMT disease are due to mutations of the
neurofilament light gene and these mutations disrupt neuro-
filament assembly and axonal transport [14, 16]. Thus, defects
in peripherin assembly caused by CMT2B-causing RAB7A
mutant proteins could, in turn, affect neurofilament assembly
and axonal transport leading to neurodegeneration. Future
experiments using cultured neurons and animal models
bearing mutations in RAB7A mimicking those found in
CMT2B patients will be instrumental to test this hypothesis.
How may RAB7A affect peripherin assembly? One
interesting possibility is that RAB7A sequesters peripherin
precursors either in the cytoplasm or on endosomal mem-
branes. This process could therefore sequester peripherin
monomers, which would not be available for neurofilament
assembly. Thus, if peripherin is involved in axonal
regeneration, as previously suggested [25, 26, 61, 67, 92],
the presence of CMT2B-causing mutants could be highly
detrimental. Another possibility is that RAB7A binding
could alter peripherin phosphorylation, either directly or
indirectly. In fact, as with other intermediate filament
proteins, peripherin is structured as a central coiled-coil
a-helical rod domain flanked by a head and a tail domain.
Head and tail domains of intermediate filament proteins are
phosphorylated at several Ser/Thr sites and this has also
been demonstrated for peripherin [3, 51, 55, 59]. Phos-
phorylation at certain sites has been shown to induce
filament disassembly [53]. Interestingly, peripherin is a
substrate for Akt [55], a kinase that is known to play a key
role in many fundamental cellular processes, such as cell
proliferation and differentiation. In neurons, Akt is also
involved in neuronal survival and axonal formation, and it
appears to have a crucial role in neuronal protection and
axonal regeneration in peripheral neurons [15, 62, 69].
Whereas RAB5A attenuates Akt signaling through the
recruitment of downstream effectors, RAB7A contributes
to the maintenance of Akt survival signaling [12, 91]. It is thus
tempting to speculate that Akt signaling could influence per-
ipherin function and that RAB7A-dependent modulation of
Akt activity may change the profile of peripherin phosphor-
ylation, thus influencing peripherin function in axonal
homeostasis. Alternatively, RAB7A mutants could indirectly
affect peripherin phosphorylation by recruiting specific
cytosolic kinases by virtue of their constitutively activated
GTP-bound state, or by transiently localizing peripherin
monomers/tetramers on endocytic membranes loaded with
active kinases. In this regard, active kinase complexes as well
as RAB7A have been found on signaling endosomes [38, 39,
52, 93], which may become sites of peripherin post-transla-
tional modification in CMT2B mutant neurons.
Further work will be necessary to define the physio-
logical importance of the interaction between RAB7A and
peripherin in vivo, and its relevance to peripheral neurons
expressing CMT2B-causing RAB7A mutants. Thus,
experiments on CMT2B cells and/or tissues are in progress
and will be fundamental to unravel molecular basis of
CMT2B peripheral neuropathy.
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